Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 3/20 | 0.42 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.42 |
| ▸ | CLK1 | P49759 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 3/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | MYC | P01106 | 1/20 | 0.33 |
| ▸ | MAX | P61244 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL664703 | 1.00 | DYRK1A (0.42) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL9256212 | 1.00 | DYRK1A (0.42) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL980374 | 0.72 | — | — | |
| SCHEMBL663387 | 0.72 | — | — | |
| SCHEMBL1904974 | 0.72 | — | — | |
| SCHEMBL19957009 | 0.72 | DYRK1A (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL22694016 | 0.71 | — | — | |
| SCHEMBL12675741 | 0.69 | PPARG (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL9709390 | 0.69 | PPARG (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL664822 | 0.69 | PPARG (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543310-B2 | COMPOSITIONS COMPRISING HFC-1234YF AND HFC-32 | CHEMOURS CO FC LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3299435-B1 | METHOD OF PREPARING A COMPOSITION COMPRISING HFC-1234YF | CHEMOURS CO FC LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20230265330-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2023-08-24 | — | — | US | disclosed |
| US-20230265330-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2023-08-24 | — | — | US | disclosed |
| US-11674067-B2 | Compositions comprising a fluoroolefin | THE CHEMOURS COMPANY FC, LLC (US) | 2023-06-13 | — | — | US | disclosed |
| US-11674067-B2 | Compositions comprising a fluoroolefin | THE CHEMOURS COMPANY FC, LLC (US) | 2023-06-13 | — | — | US | disclosed |
| US-20220389297-A1 | COMPOSITIONS COMPRISING A FLUOROOLEFIN | THE CHEMOURS COMPANY FC, LLC (US) | 2022-12-08 | — | — | US | disclosed |
| US-20210355360-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-11-18 | — | — | US | disclosed |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-07-08 | — | — | US | disclosed |
| US-7208100-B2 | 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane refrigerant compositions comprising a fluoroether and uses thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-24 | — | — | US | disclosed |
| US-7208100-B2 | 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane refrigerant compositions comprising a fluoroether and uses thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-24 | — | — | US | disclosed |
| US-7201855-B2 | 1,1,1,3,3-pentafluorobutane refrigerant compositions comprising fluoroether and uses thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-10 | — | — | US | disclosed |
| US-7201855-B2 | 1,1,1,3,3-pentafluorobutane refrigerant compositions comprising fluoroether and uses thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-10 | — | — | US | disclosed |
| US-7198728-B2 | 1-ethoxy-1,1,2,2,3,3,4,4,4,-nonafluorobutane refrigerant compositions comprising a hydrocarbon and uses thereof | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-03 | — | — | US | disclosed |
| US-7198728-B2 | 1-ethoxy-1,1,2,2,3,3,4,4,4,-nonafluorobutane refrigerant compositions comprising a hydrocarbon and uses thereof | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-03 | — | — | US | disclosed |
| US-7157020-B2 | Refrigerant compositions comprising performance enhancing additives | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-01-02 | — | — | US | disclosed |
| US-7157020-B2 | Refrigerant compositions comprising performance enhancing additives | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-01-02 | — | — | US | disclosed |
| US-5416224-A | Reaction of acetyldihydro-2-(3H)-furanone with aldehyde and alkali metal hydroxide | HENKEL CORPORATION (US) | 1995-05-16 | — | — | US | disclosed |
| WO-1992010487-A1 | PROCESS FOR CONVERTING α-ACYL-SUBSTITUTED LACTONES TO α-ALKYLIDENE-SUBSTITUTED LACTONES | HENKEL CORPORATION (US) | 1992-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355360-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | DYRK1A 4075/4885DYRK1B 4150/4885CLK1 3524/4885 |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | DYRK1A 4075/4885DYRK1B 4150/4885CLK1 3524/4885 |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | DYRK1A 4075/4885DYRK1B 4150/4885CLK1 3524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.